世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Middle East Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR/Cas9, ZFN), By Delivery Method (Ex Vivo. In Vivo), By Application, By Mode (Contract, In-house), By End Use, By Country, And Segment Forecasts, 2025 - 2033

Middle East Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR/Cas9, ZFN), By Delivery Method (Ex Vivo. In Vivo), By Application, By Mode (Contract, In-house), By End Use, By Country, And Segment Forecasts, 2025 - 2033


Middle East Genome Editing Market Trends The Middle East genome editing market size was estimated at USD 272.8 million in 2024 and is projected to reach USD 668.6 million by 2033, growing at a ... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
Grand View Research
グランドビューリサーチ
2025年8月29日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
電子ファイル - ご注文後3営業日前後 90 英語

 

Summary

Middle East Genome Editing Market Trends

The Middle East genome editing market size was estimated at USD 272.8 million in 2024 and is projected to reach USD 668.6 million by 2033, growing at a CAGR of 9.78% from 2025 to 2033. This growth is primarily driven by increasing investments in biotechnology research, rising prevalence of genetic disorders, expanding applications of CRISPR and other gene-editing technologies in agriculture and healthcare, and supportive government initiatives to advance genomic medicine. Moreover, strategic collaborations between regional research institutions and global biotech firms further accelerate regional innovation and market expansion.

Widespread Adoption of CRISPR Technologies

The Middle East is witnessing a rapid uptake of CRISPR-based genome editing technologies, driven by their precision, efficiency, and cost-effectiveness compared to earlier methods such as zinc finger nucleases and TALENs. This surge in adoption is closely tied to the region’s pressing healthcare needs, particularly the high prevalence of monogenic disorders like sickle cell anemia, beta-thalassemia, and certain metabolic syndromes. National genomics initiatives in Saudi Arabia, Qatar, and the UAE generate vast genetic datasets, creating fertile ground for CRISPR-enabled research in functional genomics, target validation, and therapeutic development. Growing investment in local research infrastructure and scientist training also reduces reliance on international expertise, accelerating the translation of genome editing from lab research to clinical applications.

Middle East Genome Editing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the Middle East genome editing market report based on technology, delivery method, application, mode, end use, and country:

• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• (CRISPR)/Cas9
• TALENs/MegaTALs
• ZFN
• Meganucleases
• Others
• Delivery Method Outlook (Revenue, USD Million, 2021 - 2033)
• Ex vivo
• In vivo
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Genetic Engineering
o Cell line engineering
o Animal genetic engineering
o Plant genetic engineering
o Others
• Clinical Applications
o Diagnostics Development
o Therapy Development
• Mode Outlook (Revenue, USD Million, 2021 - 2033)
• Contract
• In-house
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Biotechnology and pharmaceutical companies
• Academic and government research institutes
• Contract research organizations
• Country Outlook (Revenue, USD Million, 2021 - 2033)
• Saudi Arabia
• UAE
• Kuwait
• Qatar
• Oman
• Rest of Middle East

ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology Segment
1.2.2. Delivery Method Segment
1.2.3. Application Segment
1.2.4. Mode Segment
1.2.5. End Use Segment
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Market Model
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Middle East Genome Editing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Widespread adoption of CRISPR technologies
3.2.1.2. National genome programs boosting regional research
3.2.2. Market restraint analysis
3.2.2.1. Challenges concerning clinical translation
3.2.2.2. Regulatory, scientific, and ethical challenges regarding the use of genetically modified products
3.3. Middle East Genome Editing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Middle East Genome Editing Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Middle East Genome Editing Market Technology Movement Analysis
4.3. Middle East Genome Editing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
4.4. (CRISPR)/Cas9
4.4.1. (CRISPR)/Cas9 market estimates and forecasts 2021 to 2033 (USD Million)
4.5. TALENs/MegaTALs
4.5.1. TALENs/MegaTALs market estimates and forecasts 2021 to 2033 (USD Million)
4.6. ZFN
4.6.1. ZFN market estimates and forecasts 2021 to 2033 (USD Million)
4.7. Meganuclease
4.7.1. Meganuclease market estimates and forecasts 2021 to 2033 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Middle East Genome Editing Market: Delivery Method Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Middle East Genome Editing Market Delivery Method Movement Analysis
5.3. Middle East Genome Editing Market Size & Trend Analysis, by Delivery Method, 2021 to 2033 (USD Million)
5.4. Ex Vivo
5.4.1. Ex vivo market estimates and forecasts 2021 to 2033 (USD Million)
5.5. In Vivo
5.5.1. In vivo market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Middle East Genome Editing Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Middle East Genome Editing Market Application Movement Analysis
6.3. Middle East Genome Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Genetic Engineering
6.4.1. Genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.2. Cell Line Engineering
6.4.2.1. Cell line engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.3. Animal Genetic Engineering
6.4.3.1. Animal genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.4. Plant Genetic Engineering
6.4.4.1. Plant genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.5. Others
6.4.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Clinical Applications
6.5.1. Clinical applications market estimates and forecasts 2021 to 2033 (USD Million)
6.5.2. Diagnostics Development
6.5.2.1. Diagnostics development market estimates and forecasts 2021 to 2033 (USD Million)
6.5.3. Therapy Development
6.5.3.1. Therapy development market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Middle East Genome Editing Market: Mode Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Middle East Genome Editing Market Mode Movement Analysis
7.3. Middle East Genome Editing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
7.4. Contract
7.4.1. Contract market estimates and forecasts 2021 to 2033 (USD Million)
7.5. In-house
7.5.1. In-house market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Middle East Genome Editing Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Middle East Genome Editing Market End Use Movement Analysis
8.3. Middle East Genome Editing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Biotechnology and Pharmaceutical Companies
8.4.1. Biotechnology and pharmaceutical companies market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Academic and Government Research Institutes
8.5.1. Academic and government research institutes market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Contract Research Organizations
8.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Middle East Genome Editing Market: Country Estimates & Trend Analysis
9.1. Country Market Share Analysis, 2024 & 2033
9.2. Country Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
9.4. Middle East
9.4.1. Saudi Arabia
9.4.1.1. Key country dynamics
9.4.1.2. Competitive scenario
9.4.1.3. Regulatory landscape
9.4.1.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
9.4.2. UAE
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Regulatory landscape
9.4.2.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
9.4.3. Kuwait
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. Regulatory landscape
9.4.3.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
9.4.4. Qatar
9.4.4.1. Key country dynamics
9.4.4.2. Competitive scenario
9.4.4.3. Regulatory landscape
9.4.4.4. Qatar market estimates and forecasts 2021 to 2033 (USD Million)
9.4.5. Oman
9.4.5.1. Key country dynamics
9.4.5.2. Competitive scenario
9.4.5.3. Regulatory landscape
9.4.5.4. Oman market estimates and forecasts 2021 to 2033 (USD Million)
9.4.6. Rest of Middle East
9.4.6.1. Key country dynamics
9.4.6.2. Competitive scenario
9.4.6.3. Regulatory landscape
9.4.6.4. Rest of Middle East market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2024
10.4. Company Profiles/Listing
10.4.1. Merck KGaA
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Takara Bio Inc.
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Revvity, Inc.
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Danaher Corporation
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. GenScript
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. New England Biolabs
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Charles River Laboratories
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Eurofins Scientific
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Lonza
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Thermo Fisher Scientific, Inc.
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート

Grand View Research社の 生物分野 での最新刊レポート

本レポートと同じKEY WORD(editing)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2025/10/22 10:26

152.71 円

177.57 円

206.90 円

ページTOPに戻る